SCHEMBL420289

SCHEMBL420289

[CH]1CCCCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699103 1.00
SCHEMBL157167 0.97
SCHEMBL8805 0.88
SCHEMBL15269897 0.88 CXCR4 (0.33)
Hydrochloric Acid SCHEMBL15732414 0.85
SCHEMBL5010069 0.81 ALDH1A1 (0.60)
Piperidine SCHEMBL8488256 0.81 ALDH1A1 (0.60)
SCHEMBL6998033 0.79 ALDH1A1 (0.56)
SCHEMBL19926560 0.78 ALDH1A1 (0.35)
SCHEMBL1699710 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3788042-A1 BCL-2 INHIBITORS BeiGene, Ltd. (KY) 2021-03-10 EP claimed
EP-0160391-A1 Carbapenem derivatives and compositions containing them SANKYO COMPANY LIMITED (JP) 1985-11-06 EP claimed
US-20240228497-A1 Pyrrolo[2, 3-b]Pyrazine-Based Bifunctional Compounds as HPK1 Degraders and the Use Thereof BEIGENE, LTD. (KY) 2024-07-11 US disclosed
WO-2024141004-A1 COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THE USE THEREOF NANJING IMMUNOPHAGE BIOTECH CO., LTD (CN) 2024-07-04 WO disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
WO-2024114782-A1 SMALL-MOLECULE MODULATORS OF SPIKE PROTEIN NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2024-06-06 WO disclosed
EP-4377318-A1 PYRROLO [2, 3-B] PYRAZINE-BASED BIFUNCTIONAL COMPOUNDS AS HPK1 DEGRADERS AND THE USE THEREOF BeiGene, Ltd. (KY) 2024-06-05 EP disclosed
US-20240166660-A1 KRAS G12C INHIBITORS BEONE MEDICINES I GMBH (CH) 2024-05-23 US disclosed
US-11945773-B2 Method for producing propionic acid derivative DAIKIN INDUSTRIES, LTD. (JP) 2024-04-02 US disclosed
US-11932596-B2 Fluorovinyl ether compound DAIKIN INDUSTRIES, LTD. (JP) 2024-03-19 US disclosed
WO-2024053502-A1 METHOD FOR PRODUCING α-CHLOROACRYLIC ACID ESTER ダイキン工業株式会社 2024-03-14 WO disclosed
US-20090156572-A1 Nitrogen-containing heterocyclic compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED 2009-06-18 US disclosed
WO-2009072643-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-11 WO disclosed
US-20080167347-A1 Antidiabetic, antiproliferative, anticancer agents; benzanilide derivatives SHIONGI & CO., LTD. (JP) 2008-07-10 US disclosed
US-20070254877-A1 Indole Derivative and Use for Treatment of Cancer TAKADA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-11-01 US disclosed
EP-1839655-A1 CTGF EXPRESSION INHIBITOR Shionogi Co., Ltd. (JP) 2007-10-03 EP disclosed
EP-1761539-A1 INDOLE DERIVATIVE AND USE FOR TREATMENT OF CANCER Takeda Pharmaceutical Company Limited (JP) 2007-03-14 EP disclosed
WO-2005118587-A1 INDOLE DERIVATIVE AND USE FOR TREATMENT OF CANCER TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-12-15 WO disclosed
US-5102997-A Antibiotics SANKYO COMPANY LIMITED (JP) 1992-04-07 US disclosed
EP-0160391-A1 Carbapenem derivatives and compositions containing them SANKYO COMPANY LIMITED (JP) 1985-11-06 EP disclosed